![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Kostine, Marie; Finckh, Axel; Bingham, Clifton O.; Visser, Karen; Leipe, Jan; Schulze-Koops, Hendrik; Choy, Ernest H.; Benesova, Karolina; Radstake, Timothy R. D. J.; Cope, Andrew P.; Lambotte, Olivier; Gottenberg, Jacques-Eric; Allenbach, Yves; Visser, Marianne; Rusthoven, Cindy; Thomasen, Lone; Jamal, Shahin; Marabelle, Aurelien; Larkin, James; Haanen, John B. A. G.; Calabrese, Leonard H.; Mariette, Xavier und Schaeverbeke, Thierry
(2021):
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
In: Annals of the Rheumatic Diseases, Bd. 80, Nr. 1: S. 36-48
Gabay, Cem; Fautrel, Bruno; Rech, Jürgen; Spertini, Francois; Feist, Eugen; Kötter, Ina; Hachulla, Eric; Morel, Jacques; Schaeverbeke, Thierry; Hamidou, Mohamed A.; Martin, Thierry; Hellmich, Bernhard; Lamprecht, Peter; Schulze-Koops, Hendrik; Courvoisier, Delphine Sophie; Sleight, Andrew und Schiffrin, Eduardo Jörge
(2018):
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.
In: Annals of the Rheumatic Diseases, Bd. 77, Nr. 6: S. 840-847
[PDF, 744kB]